VECTIVBIO HOLDING - Stock (VECT)

CUSIP: H9060V101

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Stock
Total 13F shares
23,273,924
Share change
-484,118
Total reported value
$113,975,727
Price per share
$4.91
Number of holders
20
Value change
-$55,528,813
Number of buys
8
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP H9060V101?
CUSIP H9060V101 identifies VECT - VECTIVBIO HOLDING - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VECTIVBIO HOLDING - Stock (VECT) as of Q4 2021

As of 31 Dec 2021, VECTIVBIO HOLDING - Stock (VECT) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,273,924 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Novo Holdings A/S, Bpifrance SA, CITADEL ADVISORS LLC, CHI Advisors LLC, EVENTIDE ASSET MANAGEMENT, LLC, Cormorant Asset Management, LP, Tekla Capital Management LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and UBS Group AG. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.